---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296256406.md"
description: "SciSparc shares are trading higher. The company announced its majority-owned subsidiary, NeuroThera Labs, has completed two tranches of non-brokered private placements, raising aggregate gross proceeds of C$5.4 million."
datetime: "2026-08-18T17:07:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296256406.md)
  - [en](https://longbridge.com/en/news/296256406.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296256406.md)
generator: "portal-rs"
---

# 

SciSparc shares are trading higher. The company announced its majority-owned subsidiary, NeuroThera Labs, has completed two tranches of non-brokered private placements, raising aggregate gross proceeds of C$5.4 million.

### Related Stocks

- [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md)

## Related News & Research

- [SciSparc’s NeuroThera Advances Enrollment in SCI-210 Autism Trial](https://longbridge.com/en/news/297830603.md)
- [NeuroThera Labs raises C$ 2.7 million in first tranche of non-brokered private placement at C$ 0.12 per unit](https://longbridge.com/en/news/295709422.md)
- [BRP Non-GAAP EPS of -C$0.18, revenue of C$2.24B](https://longbridge.com/en/news/297897455.md)
- [Mulvihill Canadian Bank Enhanced Yield ETF declares CAD 0.12 dividend](https://longbridge.com/en/news/298227992.md)
- [SciSparc subsidiary NeuroThera Labs raises C$5.4 million in private placements](https://longbridge.com/en/news/296225798.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**